Lyme disease is among the most typical infectious illnesses within the U . s . States with about 329,000 new cases every year, statistically released in 2015 through the CDC. Lyme disease is really a potentially disabling infection brought on by bacteria transmitted with the bite of the infected tick to individuals and pets.
The effectiveness and recognized regimen of antibiotic strategy to Lyme disease is a reason for significant contention among physicians and patients.
Recently printed research finds the Lyme bacteria, Borrelia burgdorferi survive a 28-day span of antibiotics when treated several weeks after infection. Additionally, the research also measured the antibody immune reaction to the bacteria both pre- and publish- treatment, because this is how current diagnostics typically evaluate Lyme disease in humans.
Lead author from the study, Monica Embers, PhD became a member of me to go over the study and it is implications. Dr Embers is an assistant professor of microbiology and immunology at Tulane College Med school and an advisor for that San Francisco Bay Area Lyme Foundation.
Borrelia burgdorferi spirochetes/CDC
Intro music: “Rapture” by Ross Bugden